Riferimento:
Gan To Kagaku Ryoho. 2011 Feb;38(2):255-7.
Autori:
Uchino R1, Kusano S, Hanada N, Ohara C, Okino T, Yamaguchi K.
Fonte:
Gan To Kagaku Ryoho. 2011 Feb;38(2):255-7.
Anno:
2011
Azione:
Acetato di octreotide (SMS) è efficace nei malati terminali di cancro con ostruzioni intestinali maligne.
Target:
Acetato di octreotide/cancro con ostruzioni intestinali maligne.
ABSTRACT
There are many reports that octreotide acetate (SMS) is effective for terminally ill cancer patients with malignant bowel obstructions such as nausea, vomiting and abdominal distension. We retrospectively found that the clinical efficacy of SMS in 23 patients with these symptoms depended on the early terminal stage(about six months until death)or middle terminal stage(within one month until death). SMS was more effective to relieve abdominal distension(p=0. 01)and these bowel symptoms occurred among cancer patients in the early terminal stage rather than in the middle terminal stage(p<0. 001).
Sostanze: